Correction to: A Multi‑Center, Open‑Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females

CNS Drugs. 2019 May;33(5):523. doi: 10.1007/s40263-019-00638-y.

Authors

Yang Xu¹, Kristin Gabriel², Yi Wang², Yanchen Zhou³, Osaro Eisele², Apinya Vutikullird⁴, Daniel D Mikol², Edward Lee²

Affiliations

¹ Amgen Inc, 1 Amgen Center Dr, Thousand Oaks, CA, 91320, USA. [email protected].
² Amgen Inc, 1 Amgen Center Dr, Thousand Oaks, CA, 91320, USA.
³ Amgen Inc, 1120 Veterans Blvd, South San Francisco, 94080, CA, USA.
⁴ WCCT Global, Cypress, CA, USA.

Abstract

The authors would like to correct the error in the publication of the original article. The correction detail is given below.

Publication types

Published Erratum